Aytu BioPharma, Inc. (AYTU)
2.00
+0.03
(+1.52%)
USD |
NASDAQ |
Oct 13, 16:00
2.00
0.00 (0.00%)
After-Hours: 20:00
Aytu BioPharma Market Cap : 21.46M for Oct. 13, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 12, 2026 | 21.13M |
| October 09, 2026 | 21.72M |
| October 08, 2026 | 21.99M |
| October 07, 2026 | 21.99M |
| October 06, 2026 | 21.99M |
| October 05, 2026 | 21.89M |
| October 02, 2026 | 22.21M |
| October 01, 2026 | 22.42M |
| September 30, 2026 | 22.96M |
| September 29, 2026 | 23.60M |
| September 28, 2026 | 23.28M |
| September 25, 2026 | 24.46M |
| September 24, 2026 | 24.78M |
| September 23, 2026 | 24.46M |
| September 22, 2026 | 23.92M |
| September 21, 2026 | 22.80M |
| September 18, 2026 | 22.74M |
| September 17, 2026 | 21.46M |
| September 16, 2026 | 21.14M |
| September 15, 2026 | 21.36M |
| September 14, 2026 | 21.47M |
| September 11, 2026 | 21.36M |
| September 10, 2026 | 22.00M |
| September 09, 2026 | 22.75M |
| September 08, 2026 | 23.51M |
| Date | Value |
|---|---|
| September 04, 2026 | 23.72M |
| September 03, 2026 | 24.53M |
| September 02, 2026 | 24.47M |
| September 01, 2026 | 24.15M |
| August 31, 2026 | 24.58M |
| August 28, 2026 | 24.15M |
| August 27, 2026 | 24.04M |
| August 26, 2026 | 24.69M |
| August 25, 2026 | 25.22M |
| August 24, 2026 | 24.79M |
| August 21, 2026 | 25.44M |
| August 20, 2026 | 24.47M |
| August 19, 2026 | 25.33M |
| August 18, 2026 | 25.33M |
| August 17, 2026 | 25.33M |
| August 14, 2026 | 25.54M |
| August 13, 2026 | 24.69M |
| August 12, 2026 | 25.33M |
| August 11, 2026 | 25.76M |
| August 10, 2026 | 25.54M |
| August 07, 2026 | 25.33M |
| August 06, 2026 | 25.01M |
| August 05, 2026 | 24.69M |
| August 04, 2026 | 23.72M |
| August 03, 2026 | 24.15M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ANI Pharmaceuticals, Inc. | 1.627B |
| Corcept Therapeutics, Inc. | 12.72B |
| Veru, Inc. | 37.34M |
| Johnson & Johnson | 598.69B |
| Eli Lilly & Co. | 1.099T |
Market Cap Related Metrics
| PS Ratio | 0.5154 |
| Price to Book Value | 0.6083 |
| Price to Free Cash Flow | 9.125 |
| Price | 2.00 |
| Earnings Yield | -83.36% |